MAPK14 and myocardial infarction: The IL-10 treatment demonstrated the downregulation of p38 mitogen-activated protein kinase activation, reduced expression of the cytokine mRNA-stabilizing protein Hur, a decreased metalloproteinase-9 (MMP-9) activity, and inhibited fibrosis after MI [88].